Skip to main content
Log in

Certolizumab pegol productive in work and play

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. UCB.New Data Show CIMZIA(TM) (certolizumab pegol) May Improve Productivity in Work and with Daily Activities for People with Crohn's Disease. Media Release: 23 Oct 2006. Available from: URL: http://www.ucb-group.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Certolizumab pegol productive in work and play. Pharmacoecon. Outcomes News 517, 5 (2006). https://doi.org/10.2165/00151234-200605170-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605170-00010

Keywords

Navigation